Steven Cha
Direttore Tecnico/Scientifico/R&S presso PROCESSA PHARMACEUTICALS, INC.
Profilo
Steven Cha is currently the Senior Vice President-Clinical Research at Processa Pharmaceuticals, Inc. He previously worked as the Chief Medical Officer at Imugene Ltd.
and NKGen Operating Biotech, Inc. Dr. Cha received his undergraduate degree from the University of California San Diego and his doctorate from Tufts University School of Medicine.
Posizioni attive di Steven Cha
| Società | Posizione | Inizio |
|---|---|---|
| PROCESSA PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 30/04/2024 |
Precedenti posizioni note di Steven Cha
| Società | Posizione | Fine |
|---|---|---|
| IMUGENE LIMITED | Direttore Tecnico/Scientifico/R&S | 01/06/2022 |
NKGen Biotech, Inc.
 NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Steven Cha
| University of California San Diego | Undergraduate Degree |
| Tufts University School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| IMUGENE LIMITED | Health Technology |
| PROCESSA PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
NKGen Biotech, Inc.
NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Health Technology |
- Borsa valori
- Insiders
- Steven Cha
